Seattle, WA, United States of America

Stephanie Beigel-Orme


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stephanie Beigel-Orme

Introduction

Stephanie Beigel-Orme is a prominent inventor based in Seattle, WA. She has made significant contributions to the field of biotechnology, particularly in the development of antimicrobial agents. With a total of three patents to her name, her work has the potential to impact the treatment of microbial infections.

Latest Patents

One of her latest patents focuses on beta-defensins, specifically polynucleotide and polypeptide molecules for zamp1, a novel member of the β-defensin family. These polypeptides and the polynucleotides encoding them exhibit antimicrobial activity, making them valuable in the study or treatment of microbial infections. Additionally, the invention includes antibodies to the zamp1 polypeptides, further enhancing its applicability in medical research.

Career Highlights

Stephanie Beigel-Orme is currently associated with Zymogenetics, Inc., where she continues to innovate and develop new solutions in biotechnology. Her work is characterized by a commitment to advancing scientific knowledge and improving health outcomes.

Collaborations

Some of her notable coworkers include David A Adler and James L Holloway, who contribute to her research endeavors and collaborative projects.

Conclusion

Stephanie Beigel-Orme's contributions to the field of biotechnology through her innovative patents and collaborations highlight her role as a leading inventor in the industry. Her work continues to pave the way for advancements in the treatment of microbial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…